Q1 Earnings Estimate for NeoGenomics Issued By William Blair

NeoGenomics, Inc. (NASDAQ:NEO – Free Report) – Equities researchers at William Blair issued their Q1 2026 earnings estimates for NeoGenomics in a report released on Tuesday, February 18th. William Blair analyst A. Brackmann expects that the medical research company will post earnings per share of $0.00 for the quarter. The consensus estimate for NeoGenomics’ current […]